| Published Date | Price Target | Price When Posted | Analyst Company | Analyst Name | Upside/Downside |
|---|---|---|---|---|---|
| November 6, 2024 | 95.00 | 49.51 | Oppenheimer | Jay Olson | 91.88% |
| November 5, 2024 | 67.00 | 50.36 | Leerink Partners | Rick Bienkowski | 33.04% |
| August 12, 2024 | 100.00 | 46.55 | Truist Financial | Joon Lee | 114.82% |
| August 6, 2024 | 84.00 | 50.11 | Needham | Gil Blum | 67.63% |
| August 6, 2024 | 59.00 | 50.01 | Stifel Nicolaus | Benjamin Burnett | 17.98% |
| August 6, 2024 | 60.00 | 50.13 | RBC Capital | Luca Issi | 19.70% |
| May 9, 2024 | 52.00 | 53.29 | Robert W. Baird | Jack Allen | -2.42% |
| November 23, 2022 | 63.00 | 55.72 | Citigroup | 13.07% | |
| August 9, 2022 | 79.30 | 81.39 | Chardan Capital | Geulah Livshits | -2.57% |
| June 17, 2022 | 98.00 | 70.73 | BMO Capital | Kostas Biliouris | 38.56% |
| April 28, 2022 | 78.00 | 51.96 | Credit Suisse | 50.12% | |
| February 16, 2022 | 170.00 | 61.97 | Needham | Gil Blum | 174.33% |
| February 15, 2022 | 120.00 | 60.97 | Leerink Partners | Rick Bienkowski | 96.82% |
| January 7, 2022 | 105.00 | 67.66 | Wells Fargo | Yanan Zhu | 55.19% |
| November 4, 2021 | 172.00 | 93.00 | Oppenheimer | Jay Olson | 84.95% |
| October 12, 2021 | 180.00 | 102.59 | Piper Sandler | Edward Tenthoff | 75.46% |
| August 16, 2021 | 160.00 | 122.55 | Canaccord Genuity | Arlinda Lee | 30.56% |
| June 11, 2021 | 171.00 | 127.00 | Roth Capital | Anthony Butler | 34.65% |
| April 21, 2021 | 172.00 | 124.93 | Jefferies | Maury Raycroft | 37.68% |
Search ( Ctrl + / )
CRISPR Therapeutics AG
CRSPNASDAQ